We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




European Market for Hip, Knee Replacements

By HospiMedica staff writers
Posted on 13 Apr 2005
An aging population and technologic advances are projected to boost the hip and knee replacement market in Europe from an estimated U.S.$1.40 billion in 2004 to $1.83 billion in 2010, according to a new report from Frost & Sullivan (Palo Alto, CA, USA), international growth consultants.

Continued pressure to reduce the number of people waiting for joint replacement surgery has been paralleled by a shift in total knee and hip replacement procedures from major replacement centers to general acute hospitals. More...
This has reduced waiting times, augmented the number of procedures performed, and stimulated market growth.

Novel manufacturing techniques and new materials technology such as bone substitutes, bioabsorbable products, specialized alloys, and innovative joint-replacement product designs are all contributing to overall market value. Medical robotics, computer-assisted surgery, minimally invasive joint-replacement surgery, and bio-engineered technologies are projected to influence the development of innovative new products.

"The challenge to industry is to overcome some of the natural prejudices that the surgeons may have concerning robotics and computer assistance during surgery and ensure that implant technologies complement the use of computers during surgery,” cautioned Tanya Pullen, industry manager at Frost & Sullivan.

The competitive landscape has been shaped by a series of major acquisitions, mergers, and joint ventures. These changes have led to a streamlining of operational logistics, including the restructuring of manufacturing, sales, and marketing activities together with a rationalization of the product portfolio and product group responsibilities.

"In addition, the market has seen a slow but deliberate emphasis away from the use of local distributors, a consolidation of related orthopedic products and service activities, and a greater emphasis on supplying the market directly through subsidiaries,” noted Ms. Pullen.




Related Links:
Frost & Sullivan

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Enteral Feeding Pump
SENTINELplus
OR Table Accessory
Angular Accessory Rail
Medical Monitor
VITALMAX 4100SL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.